Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NBK
|
|||
| Former ID |
DNC002599
|
|||
| Drug Name |
Pyridoxamine-5'-Phosphate
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H13N2O5P
|
|||
| Canonical SMILES |
CC1=NC=C(C(=C1O)CN)COP(=O)(O)O
|
|||
| InChI |
1S/C8H13N2O5P/c1-5-8(11)7(2-9)6(3-10-5)4-15-16(12,13)14/h3,11H,2,4,9H2,1H3,(H2,12,13,14)
|
|||
| InChIKey |
ZMJGSOSNSPKHNH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 529-96-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:18335
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Branched-chain-amino-acid transaminase 2 (BCAT2) | Target Info | Inhibitor | [1] |
| Mycobacterium Biosynthetic alanine racemase (MycB alr) | Target Info | Inhibitor | [1] | |
| Staphylococcus D-amino acid aminotransferase (Stap-coc dat) | Target Info | Inhibitor | [1] | |
| BioCyc | Leucine degradation | |||
| Valine degradation | ||||
| Isoleucine degradation | ||||
| KEGG Pathway | Valine, leucine and isoleucine degradation | |||
| Valine, leucine and isoleucine biosynthesis | ||||
| Pantothenate and CoA biosynthesis | ||||
| Metabolic pathways | ||||
| Biosynthesis of antibiotics | ||||
| 2-Oxocarboxylic acid metabolism | ||||
| Biosynthesis of amino acids | ||||
| Panther Pathway | Alanine biosynthesis | |||
| Isoleucine biosynthesis | ||||
| Leucine biosynthesis | ||||
| Valine biosynthesis | ||||
| WikiPathways | Metabolism of amino acids and derivatives | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.